Physician profile
Jon B Smucker
NPI 1093918476
$14,663.93
in general payments reported to CMS, 2019-2025
5 companies · $1,164 in 2025
The $1,164 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,473 · 2020: $17.47 · 2021: $270 · 2022: $56.25 · 2023: $1,124 · 2024: $11K · 2025: $1,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Travel and Lodging: $4,043 · Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Travel and Lodging | $4,043.33 |
| Food and Beverage | $1,303.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $12,030.20 | 2022-2025 | Infinity Knee System, Livatec Knee Preservation System, Biobrace 23mm |
| Arthrosurface Incorporated | $1,428.28 | 2019 | |
| Stryker Corporation | $964.85 | 2021-2025 | Variax, Na, Gamma |
| Zimmer Biomet Holdings, INC. | $205.94 | 2019-2025 | Orthogrid Hip, Rosa |
| Amgen INC. | $34.66 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Smucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.